全文获取类型
收费全文 | 2883610篇 |
免费 | 222795篇 |
国内免费 | 5454篇 |
专业分类
耳鼻咽喉 | 38888篇 |
儿科学 | 95169篇 |
妇产科学 | 80087篇 |
基础医学 | 409877篇 |
口腔科学 | 85717篇 |
临床医学 | 259302篇 |
内科学 | 558073篇 |
皮肤病学 | 63709篇 |
神经病学 | 228893篇 |
特种医学 | 112124篇 |
外国民族医学 | 708篇 |
外科学 | 437621篇 |
综合类 | 70202篇 |
现状与发展 | 6篇 |
一般理论 | 1015篇 |
预防医学 | 220586篇 |
眼科学 | 68354篇 |
药学 | 214989篇 |
9篇 | |
中国医学 | 6369篇 |
肿瘤学 | 160161篇 |
出版年
2018年 | 30342篇 |
2017年 | 23371篇 |
2016年 | 25782篇 |
2015年 | 29546篇 |
2014年 | 40994篇 |
2013年 | 61182篇 |
2012年 | 83875篇 |
2011年 | 88483篇 |
2010年 | 52394篇 |
2009年 | 49275篇 |
2008年 | 83229篇 |
2007年 | 88196篇 |
2006年 | 89086篇 |
2005年 | 85833篇 |
2004年 | 83740篇 |
2003年 | 79976篇 |
2002年 | 77619篇 |
2001年 | 140882篇 |
2000年 | 144935篇 |
1999年 | 121322篇 |
1998年 | 32871篇 |
1997年 | 29254篇 |
1996年 | 29203篇 |
1995年 | 28201篇 |
1994年 | 26242篇 |
1993年 | 24411篇 |
1992年 | 96155篇 |
1991年 | 93405篇 |
1990年 | 90540篇 |
1989年 | 87333篇 |
1988年 | 80467篇 |
1987年 | 78882篇 |
1986年 | 74983篇 |
1985年 | 71963篇 |
1984年 | 53327篇 |
1983年 | 45808篇 |
1982年 | 26383篇 |
1981年 | 23603篇 |
1979年 | 49432篇 |
1978年 | 34091篇 |
1977年 | 28979篇 |
1976年 | 27217篇 |
1975年 | 28791篇 |
1974年 | 35126篇 |
1973年 | 33773篇 |
1972年 | 31187篇 |
1971年 | 29259篇 |
1970年 | 27059篇 |
1969年 | 25338篇 |
1968年 | 23338篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
Tengzhi Liu Kathrine Røe Redalen Morten Karlsen 《Journal of labelled compounds & radiopharmaceuticals》2022,65(7):191-202
Cyclotron-produced copper-64 radioisotope tracers offer the possibility to perform both diagnostic investigation by positron emission tomography (PET) and radiotherapy by a theranostic approach with bifunctional chelators. The versatile chemical properties of copper add to the importance of this isotope in medicinal investigation. [64Cu][Cu (ATSM)] has shown to be a viable candidate for imaging of tumor hypoxia; a critical tumor microenvironment characteristic that typically signifies tumor progression and resistance to chemo-radiotherapy. Various production and radiosynthesis methods of [64Cu][Cu (ATSM)] exist in labs, but usually involved non-standardized equipment with varying production qualities and may not be easily implemented in wider hospital settings. [64Cu][Cu (ATSM)] was synthesized on a modified GE TRACERlab FXN automated synthesis module. End-of-synthesis (EOS) molar activity of [64Cu][Cu (ATSM)] was 2.2–5.5 Ci/μmol (HPLC), 2.2–2.6 Ci/μmol (ATSM-titration), and 3.0–4.4 Ci/μmol (ICP-MS). Radiochemical purity was determined to be >99% based on radio-HPLC. The final product maintained radiochemical purity after 20 h. We demonstrated a simple and feasible process development and quality control protocols for automated cyclotron production and synthesis of [64Cu][Cu (ATSM)] based on commercially distributed standardized synthesis modules suitable for PET imaging and theranostic studies. 相似文献
22.
23.
24.
Xiumei Jiang Xiaowei Zhang Patrick Gray Jiwen Zheng Timothy R. Croley Peter P. Fu 《journal of environmental science and health part c-environmental carcinogenesis & ecotoxicology reviews》2019,37(2):116-131
Gold nanoparticles (Au NPs) hold great promise in food, industrial and biomedical applications due to their unique physicochemical properties. However, influences of the gastrointestinal tract (GIT), a likely route for Au NPs administration, on the physicochemical properties of Au NPs has been rarely evaluated. Here, we investigated the influence of GIT fluids on the physicochemical properties of Au NPs (5, 50, and 100?nm) and their implications on intestinal epithelial permeability in vitro. Au NPs aggregated in fasted gastric fluids and generated hydroxyl radicals in the presence of H2O2. Cell studies showed that GIT fluids incubation of Au NPs affected the cellular uptake of Au NPs but did not induce cytotoxicity or disturb the intestinal epithelial permeability. 相似文献
25.
Adjuvant irradiation is the standard treatment after breast conservative surgery. Normofractionated regimen with an overall treatment time of 5 to 6 weeks is often considered as a limiting factor for irradiation compliance. In order to answer this issue, moderate and more recently extreme hypofractionated protocols appeared. We report here oncological outcomes and toxicity of hypofractionated breast irradiation. After defining the frame of moderate and extreme hypofractionated breast irradiations based on overall treatment time, patient selection criteria were listed. According to their levels of proof, the results of moderate and extreme hypofractionated breast irradiation were analysed. Overall treatment time for moderate hypofractionated breast irradiation ranged from 3 to 4 weeks, while for extreme hypofractionated breast irradiation, it was less than 1 week. For moderate hypofractionated breast irradiation, whole breast irradiation was currently performed with or without lymph node irradiation. Moderate hypofractionated breast irradiation has proven to be as safe and as efficient as normofractionated breast irradiation with level IA evidence. For extreme hypofractionated breast irradiation, phase III randomized trials confirmed that accelerated partial breast irradiation was non-inferior in terms of local control compared to normofractionated whole breast irradiation (with external beam radiation therapy and multicatheter brachytherapy), with similar acute and late toxicity. While the use of intraoperative breast irradiation remains under debate, new very accelerated partial breast irradiation (overall treatment time not exceeding 2 days) protocols emerged with encouraging results. Accelerated partial breast irradiation is warranted for extreme hypofractionated breast irradiation and is indicated for low-risk breast cancers. Moderate and extreme hypofractionated breast irradiation regimens are validated and can be routinely proposed according to patient selection criteria. 相似文献
26.
27.
28.
29.
30.